Source comparison
Quickcomparison
Dose Range Tabimorelin 100–500 mg MK-677 (Ibutamoren) 10–25 mg Frequency Once daily Administration Oral (capsule or solution) Oral (capsule or liquid) Cycle Length 4-6 weeks 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phas
This comparison does not assign a generated winner or score.
- Dose Range
- Tabimorelin
- 100–500 mg
- MK-677 (Ibutamoren)
- 10–25 mg
- Frequency
- Once daily
- Administration
- Oral (capsule or solution)
- Oral (capsule or liquid)
- Cycle Length
- 4-6 weeks
- 8-12 weeks
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Efficacy